These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 3720217

  • 1. Low-dose weekly oral methotrexate therapy for inflammatory arthritis.
    Boh LE, Schuna AA, Pitterle ME, Adams EM, Sundstrom WR.
    Clin Pharm; 1986 Jun; 5(6):503-8. PubMed ID: 3720217
    [Abstract] [Full Text] [Related]

  • 2. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 3. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R.
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of rheumatoid arthritis with low dose pulse methotrexate--comparative study with other disease modifying antirheumatic drugs].
    Murayama T, Ubukata A, Nakazaki S.
    Ryumachi; 1992 Feb; 32(1):3-11. PubMed ID: 1604414
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 6. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 7. [Low dose methotrexate therapy in rheumatoid arthritis].
    Shinozawa T, Akama H, Matsushita Y, Tanaka H, Yamada H, Suzuki Y, Ichikawa Y, Homma M.
    Ryumachi; 1990 Jun; 30(3):172-80. PubMed ID: 2244252
    [Abstract] [Full Text] [Related]

  • 8. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.
    Morassut P, Goldstein R, Cyr M, Karsh J, McKendry RJ.
    J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE, Bochkova AG, Bunchuk NV.
    Ter Arkh; 2008 Mar; 80(5):25-30. PubMed ID: 18590110
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
    Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA, Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.
    Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
    [Abstract] [Full Text] [Related]

  • 11. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.
    Gabriel S, Creagan E, O'Fallon WM, Jaquith J, Bunch T.
    J Rheumatol; 1990 Apr; 17(4):460-5. PubMed ID: 2348423
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM, Cohen SB, Moreland LW, Schiff M, Mease PJ, Smith DB, Keenan G, Kremer JM, iRAMT Study Group.
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study.
    Mielants H, Veys EM, Van der Straeten C, Ackerman C, Goemaere S.
    J Rheumatol; 1991 Jul; 18(7):978-83. PubMed ID: 1920332
    [Abstract] [Full Text] [Related]

  • 14. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 15. [Treatment with low-dose methotrexate in chronic polyarthritis. Review of the literature].
    Rau R.
    Z Rheumatol; 1986 Jan; 45(6):283-95. PubMed ID: 3548154
    [Abstract] [Full Text] [Related]

  • 16. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ.
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost].
    Ka MM, Diallo S, Ka EF, Diop BM, Pouye A, Mbengue M, Leye A, Diouf B, Diop TM.
    Sante; 2000 Feb; 10(1):65-8. PubMed ID: 10827366
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 19. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
    Weinblatt ME, Maier AL, Fraser PA, Coblyn JS.
    J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
    [Abstract] [Full Text] [Related]

  • 20. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.